Iovance Biotherapeutics Inc
IOVA
$14.50-0.41%
End of day · as of Oct 14, 2026, 8:00 AM ET
Mkt cap
$1.89B
EV/Sales
6.55
P/E ratio
N/A
FY2025 Revenue
$263.50M
EPS (TTM)
$-0.69
Gross Margin (FY2025)
34.28%
Profit Margin (FY2025)
-148.38%
Beta
0.70
Div yield
N/A
Sector
Healthcare
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Latest reported IOVA revenue for 2025-12-31 was $263.5M. Net income was -$391.0M. Revenue was up 60.6% from 2024-12-31 to 2025-12-31. IOVA currently screens at market cap $1.89B.
Use this IOVA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IOVA income, balance, and cash tables.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company in the Healthcare sector.
Latest cached Iovance Biotherapeutics Inc (IOVA) revenue for Dec 31, 2025 was $263.5M. Net income was -$391.0M. Statements: https://lician.com/financials/iova
Iovance Biotherapeutics Inc (IOVA) market capitalization is $1.89B on the latest cached snapshot.
Iovance Biotherapeutics Inc (IOVA) cached previous close $14.56; day range $14.48 – $14.50; volume 11,915,413. Session quote: https://lician.com/quote/iova
Iovance Biotherapeutics Inc (IOVA) latest cached earnings event is "IOVA earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IOVA filing is 8-K · Oct 5, 2026. Filings: https://lician.com/sec/iova